Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.

[1]  J. Buckner,et al.  A patient-level meta-analytic investigation of the prognostic significance of baseline quality of life (QOL) for overall survival (OS) among 3,704 patients participating in 24 North Central Cancer Treatment Group (NCCTG) and Mayo Clinic Cancer Center (MC) oncology clinical trials , 2008 .

[2]  C. Gotay,et al.  The prognostic significance of patient-reported outcomes in cancer clinical trials. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  C. Gotay,et al.  Prognostic factor analysis of health-related quality of life data in cancer: a statistical methodological evaluation , 2008, Expert review of pharmacoeconomics & outcomes research.

[4]  D. Patrick,et al.  Patient-reported outcomes to support medical product labeling claims: FDA perspective. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[5]  C. Gotay,et al.  Patient‐reported Outcomes in Cancer: A Review of Recent Research and Policy Initiatives , 2007, CA: a cancer journal for clinicians.

[6]  J. Jett,et al.  A pooled analysis of quality of life measures and adverse events data in north central cancer treatment group lung cancer clinical trials , 2007, Cancer.

[7]  G. Giaccone,et al.  Is a patient's self-reported health-related quality of life a prognostic factor for survival in non-small-cell lung cancer patients? A multivariate analysis of prognostic factors of EORTC study 08975. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[8]  T. Mok,et al.  Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[9]  K. Van Steen,et al.  Does a patient's self-reported health-related quality of life predict survival beyond key biomedical data in advanced colorectal cancer? , 2006, European journal of cancer.

[10]  L. Collette,et al.  Is baseline quality of life useful for predicting survival with hormone-refractory prostate cancer? A pooled analysis of three studies of the European Organisation for Research and Treatment of Cancer Genitourinary Group. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  A. Norman,et al.  Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  D. Osoba,et al.  Quality of life scores: An independent prognostic variable in a general population of cancer patients receiving chemotherapy , 2004, Quality of Life Research.

[13]  D. Roychowdhury,et al.  Health-related quality-of-life parameters as independent prognostic factors in advanced or metastatic bladder cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  A. Norman,et al.  Baseline quality of life predicts survival in patients with advanced colorectal cancer. , 2002, European journal of cancer.

[15]  Frank E. Harrell,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .

[16]  R. Gelber,et al.  Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  N. Sengupta,et al.  PPO8: AN EMPIRICAL ANALYSIS ON AMBULATORY CARE UTILIZATION: APPLICATION OF A COUNT DATA MODEL , 1999 .

[18]  J. Holland,et al.  Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? , 1999, Cancer.

[19]  D. Osoba,et al.  Interpreting the significance of changes in health-related quality-of-life scores. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  J. Hilton,et al.  The appropriateness of the Wilcoxon test in ordinal data. , 1996, Statistics in medicine.

[21]  F. Harrell,et al.  Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors , 2005 .

[22]  Andrew Bottomley,et al.  EORTC QLQ-C30 Scoring Manual , 1995 .

[23]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[24]  M Schumacher,et al.  A bootstrap resampling procedure for model building: application to the Cox regression model. , 1992, Statistics in medicine.

[25]  P. Ganz,et al.  Assessing the quality of life--a study in newly-diagnosed breast cancer patients. , 1990, Journal of clinical epidemiology.

[26]  G. Guyatt,et al.  Measurement of health status. Ascertaining the minimal clinically important difference. , 1989, Controlled clinical trials.

[27]  D. Cox.  Regression Models and Life-Tables , 1972 .